Subcutaneous implantable cardioverter defibrillator and defibrillation testing: a propensity-matched pilot study.

[1]  M. Biffi,et al.  Is 40 Joules Enough to Successfully Defibrillate With Subcutaneous Implantable Cardioverter Defibrillators? , 2021, JACC. Clinical electrophysiology.

[2]  M. Biffi,et al.  Clinical impact of defibrillation testing in a real‐world S‐ICD population: Data from the ELISIR registry , 2020, Journal of cardiovascular electrophysiology.

[3]  M. Biffi,et al.  Implantation technique and optimal subcutaneous defibrillator chest position: a PRAETORIAN score-based study. , 2020, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[4]  W. van der Stuijt,et al.  Defibrillation testing during implantation of the subcutaneous implantable cardioverter-defibrillator: a necessary standard or becoming redundant? , 2020, Netherlands Heart Journal.

[5]  J. Curtis,et al.  Prevalence, predictors and complications with defibrillation threshold testing in pediatric patients: Results from the NCDR. , 2020, International journal of cardiology.

[6]  A. Wilde,et al.  A novel tool to evaluate the implant position and predict defibrillation success of the subcutaneous implantable cardioverter-defibrillator: The PRAETORIAN score. , 2019, Heart rhythm.

[7]  A. León,et al.  Effect of defibrillation threshold testing on effectiveness of the subcutaneous implantable cardioverter defibrillator , 2018, Pacing and clinical electrophysiology : PACE.

[8]  M. Shoukri,et al.  Subcutaneous Implantable Cardioverter Defibrillators Implantation Without Defibrillation Threshold Testing: A Single Center Experience , 2017, Cardiology research.

[9]  A. Russo,et al.  Trends and In-Hospital Outcomes Associated With Adoption of the Subcutaneous Implantable Cardioverter Defibrillator in the United States. , 2016, JAMA cardiology.

[10]  David E Haines,et al.  2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing. , 2016, Heart rhythm.

[11]  J. Svendsen,et al.  Intra-operative defibrillation testing and clinical shock efficacy in patients with implantable cardioverter-defibrillators: the NORDIC ICD randomized clinical trial , 2015, European heart journal.

[12]  J. Pogue,et al.  Cardioverter defibrillator implantation without induction of ventricular fibrillation: a single-blind, non-inferiority, randomised controlled trial (SIMPLE) , 2015, The Lancet.

[13]  M. Chung,et al.  Is Defibrillation Testing Necessary for Implantable Transvenous Defibrillators?: Defibrillation Testing Is Necessary at the Time of Implantable Cardioverter Defibrillator Implantation , 2014, Circulation. Arrhythmia and electrophysiology.

[14]  N. Estes Defibrillation testing: should the paradigm shift? , 2012, Journal of the American College of Cardiology.

[15]  N. Boyle,et al.  Defibrillation threshold testing fails to show clinical benefit during long-term follow-up of patients undergoing cardiac resynchronization therapy defibrillator implantation. , 2011, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[16]  M. Brignole,et al.  Defibrillation testing at the time of implantation of cardioverter defibrillator in the clinical practice: a nation-wide survey. , 2007, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[17]  H. Karagueuzian,et al.  On the mechanism of the probabilistic nature of ventricular defibrillation threshold , 2003 .

[18]  M. Gold,et al.  Efficacy and Temporal Stability of Reduced Safety Margins for Ventricular Defibrillation: Primary Results From the Low Energy Safety Study (LESS) , 2002, Circulation.